About The Catholic University of Korea, Daejeon ST. Mary's Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at The Catholic University of Korea, Daejeon ST. Mary's Hospital
During the past decade, The Catholic University of Korea, Daejeon ST. Mary's Hospital conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 5 clinical trials were completed, i.e. on
average, 12.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 3 clinical trials were completed. i.e. 23.1%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Catholic University of Korea, Daejeon ST. Mary's Hospital" #1 sponsor was "Seung-Jung Park" with 23 trials, followed by "Eli Lilly and Company" with 4 trials
sponsored, "Pfizer" with 3 trials sponsored, "The Catholic University of Korea" with 3 trials sponsored and "Duk-Woo Park, MD"
with 3 trials sponsored. Other sponsors include 27 different institutions and
companies that sponsored additional 33 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Catholic University of Korea, Daejeon ST. Mary's Hospital"
#1 collaborator was "CardioVascular Research Foundation, Korea" with 26 trials as a collaborator, "Abbott" with 4 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "Amg Korea Co. Ltd." with 1 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were
collaborators in the rest 34 trials.
Clinical Trials Conditions at The Catholic University of Korea, Daejeon ST. Mary's Hospital
According to Clinical.Site data, the most researched conditions in "The Catholic University of Korea, Daejeon ST. Mary's Hospital" are
"Coronary Artery Disease" (23 trials), "Crohn's Disease" (4 trials), "Coronary Disease" (3 trials), "Coronary Stenosis" (3 trials) and "Angioplasty, Transluminal, Percutaneous Coronary" (2 trials). Many other conditions were trialed in "The Catholic University of Korea, Daejeon ST. Mary's Hospital" in a lesser frequency.
Clinical Trials Intervention Types at The Catholic University of Korea, Daejeon ST. Mary's Hospital
Most popular intervention types in "The Catholic University of Korea, Daejeon ST. Mary's Hospital" are "Drug" (24 trials), "Device" (19 trials), "Procedure" (7 trials) and "Biological" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Mirikizumab" (3 trials), "Ustekinumab" (3 trials), "BIOFREEDOM™ FAMILY stent" (1 trials) and "BR-TD-1001" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Catholic University of Korea, Daejeon ST. Mary's Hospital
The vast majority of trials in "The Catholic University of Korea, Daejeon ST. Mary's Hospital" are
66 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at The Catholic University of Korea, Daejeon ST. Mary's Hospital
Currently, there are NaN active trials in "The Catholic University of Korea, Daejeon ST. Mary's Hospital".
undefined are not yet recruiting,
15 are recruiting,
10 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 24 completed trials in The Catholic University of Korea, Daejeon ST. Mary's Hospital,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in The Catholic University of Korea, Daejeon ST. Mary's Hospital, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 13 trials, and there were
also 4 trials that are defined as “Not Applicable".